B. Woodcock

发表

Thrombocytopenia with rituximab treatment—splenomegaly as the risk factor

J. Thachil, I. Hincks, R. Salim, 2009, Annals of Hematology.

Fludarabine treatment and transfusion-associated graft-versus-host disease

L. Williamson, J. Wimperis, M. Wood, 1996, The Lancet.

Antithrombins Southport (Leu 99 to Val) and Vienna (Cln 118 to Pro): two novel antithrombin variants with abnormal heparin binding

I. Pabinger, T. Barrowcliffe, D. Lane, 1995, British journal of haematology.

Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia.

J. D. van der Walt, P. Campbell, A. Green, 2005, The New England journal of medicine.

Gene expression profiling in the myelodysplastic syndromes using cDNA microarray technology

C. Langford, D. Vetrie, J. Cavenagh, 2004, British journal of haematology.

Late-onset X-linked sideroblastic anemia. Missense mutations in the erythroid delta-aminolevulinate synthase (ALAS2) gene in two pyridoxine-responsive patients initially diagnosed with acquired refractory anemia and ringed sideroblasts.

D. Bishop, A. May, P. Cotter, 1995, The Journal of clinical investigation.

Red cell aplasia due to parvovirus b19 in a patient treated with alemtuzumab

B. Crowley, B. Woodcock, 2002, British journal of haematology.

Rituximab‐induced haemorrhagic thrombocytopenia in a patient with hairy cell leukaemia

J. Thachil, B. Woodcock, Kingshuk Mukherje, 2006, British journal of haematology.

Late-onset X-Linked Sideroblastic Anemia

D. Bishop, A. May, E. Fitzsimons, 2013 .

Is Rituximab‐induced Late‐onset Neutropenia a good prognostic indicator in lymphoproliferatve disorders?

J. Thachil, I. Hincks, B. Woodcock, 2011, British journal of haematology.

Effects of dietary fish oil supplementation on the fatty acid composition of the human platelet membrane: demonstration of selectivity in the incorporation of eicosapentaenoic acid into membrane phospholipid pools.

M. Greaves, F. Preston, R. Graham, 1985, Clinical science.